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Abstract
Background: Robotic exoskeletons are increasingly being used in objective and quantitative assessment of upper
limb (UL) movements. A set of instrumental indices computed during robot-assisted reaching tasks with the
Armeo®Spring has been proven to assess UL functionality. The aim of this study was to test the construct
validity of this indices-based UL assessment when used with patients who have had a stroke.
Methods: Forty-four 45- to 79-year-old stroke patients with a Wolf Motor Function Test ability score (WMFT-FAS)
ranging from 10 to 75 and a Motricity Index (MI) ranging from 14 to 33 at shoulder and elbow were enrolled, thus
covering a wide range of impairments. Residual UL function was assessed by both the WMFT-FAS and the WMFT-TIME,
as well as by a set of 9 numerical indices assessing movement accuracy, velocity and smoothness computed from a 3D
endpoint trajectory obtained during the “Vertical Capture” task of the Armeo®Spring device. To explore which variables
better represented motor control deficits, the Mann-Whitney U Test was used to compare patients’ indices to those
obtained from 25 healthy individuals. To explore the inner relationships between indices and construct validity in
assessing accuracy, velocity and smoothness, a factor analysis was carried out. To verify the indices concurrent validity,
they were compared to both WMFT-FAS and WMFT-TIME by the Spearman’s correlation coefficient.
Results: Seven indices of stroke subjects were significantly different from those of healthy controls, with effect sizes in
the range 0.35–0.74. Factor analysis confirmed that specific subsets of indices belonged to the domains of accuracy,
velocity and smoothness (discriminant validity). One accuracy index, both velocity indices and two smoothness indices
were significantly correlated with WMFT-FAS and WMFT-TIME (|rho| = 0.31–0.50) (concurrent validity). One index for
each of the assessed movement domains was proven to have construct validity (discriminant and concurrent) and was
selected. Moreover, the indices were able to detect differences in accuracy, velocity and/or smoothness in patients with
the same WMFT level.
Conclusions: The proposed index-based UL assessment can be used to integrate and support clinical evaluation of UL
function in stroke patients.
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Background
Upper-extremity impairment is the most significant and
persistent physical disability in stroke survivors, being
reported in about 70 % of patients on admission subse-
quent to a stroke [1]. This may determine a great reduc-
tion in the reaching ability needed to perform everyday
activities and, consequently, in their independence [2].
Quantifying the reaching ability in stroke patients, which
is necessary to determine the initial loss of movement
and function, is essential in order to track the motor re-
covery throughout the rehabilitation period, and relies
on clinical scales. The most common scoring systems in
this field are the Fugl-Meyer Motor Performance Assess-
ment (FMA) [3–6] to assess motor impairment and the
WMFT [7–9] to evaluate UL function. With respect to
the International Classification of Functioning, Disability
and Health (ICF), [10] the FMA only deals with the body
function domain, while the WMFT is classified in terms
of ICF categories as an Activity Scale, as it measures
changes in functional activities [11]. These tests have
proven their reliability [12] and validity [13–15] when
assessing UL function in stroke patients, despite some
minor limitations [16–18], such as equipment needs,
time of execution, training requirements and the lack of
sensitivity to subtle changes in motor performance
throughout the rehabilitation process.
The recovery in UL movement, if any, typically begins
in the sub-acute stage after a stroke and is supported by
personalized rehabilitation programs, the positive out-
come of which is known to depend on repetition, inten-
sity and task-orientation [19]. For this reason, robotic
devices and exoskeletons that support the upper limb
during execution of repetitive tasks have been intro-
duced as part of overall treatment aimed at restoring
upper extremity functionality [20–22]. Apart from their
use in the rehabilitative practice, the availability of em-
bedded sensors could permit a further use as an assess-
ment device. In fact, UL robotic rehabilitation devices
have recently been used as an objective and accurate
assessment tool to monitor progress [23] and to collect
quantitative data that summarize individual performance
[24]. The duration of robot-based tests, as reported in
related literature, lasts generally no less than 30–40
minutes [25–27], with the number of parameters
extracted from the robot-assisted upper limb trajectory
being largely variable among studies, varying from 5
smoothness parameters in the study by Roher and col-
leagues [28] up to 22 indices that contributed to creating
a single composite score in the paper by Einav et al.
[25]. In general, as summarized in the review by Nordin
et al. [29], several indicators have been proposed in the
literature to describe UL impairment in stroke patients,
dealing with movement planning, accuracy, coordin-
ation, efficiency, velocity, acceleration, jerkiness and
number of movement sub-units. However, a complete
analysis of their metric characteristics and concurrent
validity with clinical scales is still missing [29].
We have recently developed a customized stand-alone
software that increases the usefulness of a commercially
available exoskeleton (Armeo®Spring, Hocoma AG,
Switzerland), by providing a set of indices aimed at
assessing accuracy, velocity and smoothness of UL mo-
tion along with the related reference values [30]. When
used with stroke patients, this assessment can be carried
out between 5 to 15 min, depending on the patient’s im-
pairment level. The derived indices are easy to share
with clinical professionals, as they refer directly to move-
ment accuracy, velocity and lack of smoothness (jerki-
ness), which are clinical aspects of UL impairment. In
fact, loss of accuracy can be related to reduction of
somatosensation, decrease of velocity due to paresis and
loss of jerkiness to abnormal muscle tone [31]. Before
being used in clinical evaluations, these indices have to
be validated by comparison with clinical scales [27]. For
this reason, we tested the validity of this UL function
assessment through instrumental indices by quantifying
their ability to distinguish between stroke patients and
healthy subjects, by identifying indices that assess differ-
ent domains of UL movement, and by verifying their
correlation with a clinical reference standard. The aim
was to give clinicians an objective, quantitative and easy-
to-use assessment tool to improve UL function evalu-
ation in neurological diseases.
Methods
Participants
Forty-four stroke patients, who were admitted to the
Rehabilitation Department of our hospital over a two-
year period (2012–2013) were selected for robotic treat-
ment by their referring physicians, and enrolled in the
study. Inclusion criteria were: (1) UL hemiparesis due to
first unilateral ischemic or hemorrhagic stroke; (2) no
serious cognitive deficits; (3) ability to sit (the Trunk
Control Test -TCT- item of “balance in sitting position”
score ≥12) and be active in a chair for one hour without
cardiac, respiratory and/or pain complaints; (4) ability to
actively move shoulder and elbow (MI ≥ 14 at both
shoulder and elbow [32]) in conditions of load relief.
Exclusion criteria were: (1) severe cognitive-perceptual
deficits (ataxia, apraxia, heminegligence, receptive apha-
sia); (2) shoulder pain or subluxation or other neuro-
logical/neuromuscular or orthopedic conditions affecting
reaching ability; (3) severe ipovisus.
This study is based on a retrospective analysis of data
available from the clinical routine in the years 2012–
2013. All patients gave informed consent to data treat-
ment in this research study and permission to publish
anonymous data and results. The conduction of this
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retrospective study did not affect patients’ treatment in
any way. It was carried out in accordance with the
standard ethical principles and was approved by the
inner scientific board of our Hospital, which has re-
ceived the formal approval for the conduction of clinical
studies from the local Ethical Committee (Comitato
Etico IRST IRCCS e Area Vasta Romagna, CEIIAV).
Normal reference data used in this study came from a
sample of 25 healthy right-handed individuals, aged
between 21 and 74 years of age (mean age = 46 ± 20 years)
and are available in the reference [30]. In this sample of
normal subjects, indices were not affected by age.
Clinical assessments
Residual UL function was assessed for each subject both
clinically and instrumentally. UL motor ability was clin-
ically assessed by the WMFT, which refers to the activ-
ities domain of the ICF [11], as it provides a quantitative
measurement of motor ability through a wide range of
functional tasks and evaluates performance time, quality
of movement and strength. The WMFT consists of 17
items: two are related to subject strength and the other
15 to subject functional ability. The mean execution
time (WMFT-TIME), expressed in seconds, is obtained
as the sum of the execution times of each task (with an
upper limit of 120 s each) divided by the number of
tasks. The total score, also referred to as Functional
Ability score (WMFT-FAS), is the sum of the 15 items
score (with a 6-point ordinal score from 0 to 5). The
maximum total score is 75, with lower scores indicating
lower functional levels.
Finally, the TCT item of “balance in sitting position”
score was reported in this paper, as well as the MI score
at shoulder and elbow, in order to clinically describe
patient functional level. Characteristics of participants
are shown in Table 1.
Robotic assessment
UL motor ability was instrumentally assessed by a set of
numerical indices based on the 3D endpoint trajectory
during the Armeo®Spring “Vertical Capture” task, as in
reference [30]. The Armeo®Spring device is a UL exo-
skeleton equipped with seven goniometers and one pres-
sure sensor, which permits free 3D arm movement and
provides a support to the weight of the arm, adjustable
over five levels. A handle based at the end of the robotic
arm, containing a pressure sensor, measures hand grip
force. Visual feedback of the subject’s hand position is
displayed and used in a set of rehabilitation games and
testing exercises. In our study, raw sensor data and the
endpoint trajectory were acquired and stored by setting
a specific software registry key, as described in the de-
vice manual.
Before any acquisition, the physiotherapist adjusted
the exoskeleton so that it fit comfortably to the subject’s
arm and set the weight support to the minimum level,
where the patients were able to maintain their forearm
in a horizontal position and to move their UL within a
45-degree range of flexion. The patient, whilst wearing
the device, practiced making a few free assisted move-
ments and was then asked to try preforming the “Verti-
cal Capture” task, described below, at the easiest level
twice in a row, without worrying about the result and
for the purpose of getting used to the device.
The purpose of the “Vertical Capture” task is to as-
sess the functional level of patients. In this task, a
target (ladybird) appears on the monitor and the sub-
ject has to place the cursor, controlled by the end-
point position, on the target. When a target is hit, it
disappears and a new one appears on the screen.
Both the number of targets and the area covered by
the targets increase with the difficulty level of the
exercise, which ranges from 1 to 4.
After practicing for approximately five minutes, each
subject executed three repetitions of the “Vertical Cap-
ture” task at the maximum difficulty level according to
their ability, which was the highest level out of four
where the patient reached the highest number of targets
(typically 100 %). Thanks to this choice, the data always
represented the best performance of each subject, ac-
cording to their residual ability and can be grouped and
compared to the performance assessed by the WMFT. A
set of indices was computed based on the 3D endpoint
trajectory. These indices are summarized in Table 2 and
fully described in reference [30].
Statistical analysis
To explore values that have the potential to distinguish
between stroke patients and healthy subjects, patient in-
dices were compared to those obtained from healthy,
right-handed reference individuals using the non-
Table 1 Demographic and clinical characteristics of the sample
Characteristic N = 44





Affected side, Left/Right 24/20
Months from lesion, mean ± st.dev. (range) 2.7 ± 3.6 (0.4–19)
WMFT-FAS, mean ± st.dev. (range) 48 ± 16 (10–75)
WMFT-TIME, s, mean ± st.dev. (range) 18.5 ± 24.5 (2.1–81.5)
MI at the shoulder, mean ± st.dev. (range) 21 ± 6 (14–33)
MI at the elbow, mean ± st.dev. (range) 23 ± 5 (14–33)
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parametric Mann-Whitney U test. As in reference [27],
the effect size (ES) was then calculated by dividing the
Z-score by the square root of the total number of partic-
ipants: ES ¼ Z= ﬃﬃﬃﬃNp .
To verify the discriminant validity of the indices when
assessing accuracy, velocity and smoothness in stroke
patients UL movement, a factor analysis was performed.
Principal Component Analysis (PCA) was applied to the
complete dataset to select the most significant features
among the set of indices that characterize UL move-
ment. The minimum number of Principal Components
(PCs) considered as significant was determined using the
Kaiser criterion; i.e. only PCs with an associated eigen-
value greater than one were taken into account. A Vari-
max rotation was performed to obtain a group of
homogeneous and significant variables for each PC [33].
The Kaiser-Meyer-Olkin (KMO) measure was used to
assess the adequacy of the analysis [34].
Then a correlation analysis was used to verify the con-
current validity of the indices with a recognized clinical
reference standard. Correlations between the investi-
gated parameters and both the WMFT-FAS and
WMFT-TIME were analyzed by the Spearman’s rank
correlation coefficient. The strength of the correlation
coefficients was interpreted according to Guilford [35]:
0.0–0.2 little if any; 0.2–0.4 weak; 0.4–0.7 moderate;
0.7–1.0 strong. As a result of having a sample size of 44
subjects, we will be able to correctly reject the null hy-
pothesis of no correlation with a power of 66 % in
the case of medium effect size (i.e. |rho| = 0.3) and
with a power of at least 98 % in the case of a large
effect size (i.e. |rho| > =0.5). The power analysis was
conducted in G-POWER using an alpha of 0.05 and a
sample size of 44.
These analyses allowed for the selection of the most
appropriate indices to be used in the analysis of UL mo-
tion in stroke patients among the set of available indices,
based on their sensitivity to the pathological condition,
their ability to assess specific domains of UL movement
and their concurrent validity with the clinical reference
standard.
Statistical analysis was performed using SPSS statistical
software (version 21.0, SPSS Inc., Chicago, IL, USA).
Statistical significance was set at 5 % for all analyses.
Results
Ability of indices to distinguish between stroke patients
and healthy subjects
The mean values of indices in the sample are presented in
Table 3, along with the corresponding normal reference
values. As expected, statistically significant differences be-
tween patient values and normal values were found.
ES ranged between 0.35 and 0.74 and was higher for
indices assessing lack of smoothness in movement
trajectory. Two specific indices, number of peaks in the
velocity profiles (NVelPeaks) and Normalized Jerk
(NormJerk), showed the best ability to distinguish be-
tween normal and pathological subjects. In general,
Table 2 Indices computed based on the 3D endpoint trajectory




HPR, % Global Hand Path Ratio, defined as the
ratio between the length of the
endpoint trajectory during the reaching
movement and the minimum distance
between the starting point and target,
expressed as a percentage. HPR equals
100 % for straight movements and
increases with the trajectory curvature
and presence of abnormal movements.
locHPR, % Local Hand Path Ratio, defined as the
ratio between the length of the endpoint
trajectory and the shortest trajectory
within a circle with a 2.5 cm radius
centered in the target, expressed as a
percentage. The locHPR equals 100 %
for straight movements towards the
target and increases if the individual
reaches the target with multiple
adjustments.
vertOS and horOS, cm Vertical and horizontal overshoot,
defined as the excess, if any, in both
a vertical and horizontal direction
beyond the region delineated by the
starting point and target.
Indices of velocity
maxVel, cm/s Maximum velocity of the velocity profile
of the 3D endpoint trajectory during
each single reaching movement.
meanVel, cm/s Mean velocity of the velocity profile of
the 3D endpoint trajectory during each
single reaching movement.
meanVel/maxVel, % Ratio between mean and maximum
velocity, expressed as a percentage.
This ratio outlines the presence of a
movement characterized by brisk
movements with stops and starts.
Indices of smoothness
NVelPeaks, adim Number of local peaks in the velocity
profile. This index counts the number
of partial movements used to complete
a single reaching movement. Also referred
to as number of movement units.
NormJerk, adim The normalized jerk is a measurement
of the trajectory smoothness. NormJerk
was computed through numerical
differentiation of the 3D endpoint trajectory
and a zero phase lag low-pass Butterworth
filtering with a cut-off frequency of 10
Hertz. NormJerk tends to be 1 for purely
sinusoidal traces and greatly increases in
the presence of acceleration variations.
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according to Cohen’s ES interpretation rule, a discrimin-
ant ability of the pathological condition ranging from
medium to large was reached by at least one index for
all of the three domains investigated. Based on ES, the
global Hand Path Ratio (HPR) should be selected to as-
sess accuracy, mean velocity (meanVel) should be se-
lected to assess velocity and NVelPeaks to assess the
lack of trajectory smoothness.
Discriminant validity of indices
Factor analysis led to the identification of three signifi-
cant factors, which accounted for 87 % of the variance in
the entire set of parameters. KMO was 0.707, thus con-
firming a good factor analysis. Figure 1 presents the out-
put of the rotation procedure. All indices expected to
assess movement accuracy (see Table 2) resulted
grouped together in factor 1, both indices assessing
movement smoothness were grouped in factor 2 and
two of the indices assessing velocity, meanVel and max-
imum velocity (maxVel), were grouped in factor 3. For
these indices, their discriminant ability to assess a spe-
cific domain of UL movement (e.g. smoothness) was
confirmed. The variable ratio between mean and max-
imum velocity (meanVel/maxVel) did not clearly fall
within a single domain and was, therefore, excluded
from further analysis.
Concurrent validity of indices
Correlation analysis was used to verify the concurrent
validity of the proposed indices by comparing them to a
clinical scale, the WMFT, which was used as a reference
standard. Weak to moderate significant correlations
were found for a subset of the indices, as presented in
Table 4.
Table 3 Values of indices for stroke patients and healthy
subjects. The 10th-90th percentile ranges are indicated
Indices Healthy subjects Stroke subjects |Effect size|
HPR, % 121–154 136–273 † 0.58
horOS, cm 0.8–2.2 1.1–3.6 † 0.35
vertOS, cm 0.6–1.7 0.3–1.8 -
locHPR, % 129–231 132–371 -
meanVel, cm/s 1.8–3.5 1.0–2.8 ** 0.55
maxVel, cm/s 5.1–10.0 3.1–10.1 * 0.42
meanVel/maxVel, % 34.4–40.1 27.6–37.2 ** 0.52
NVelPeaks, adim 1.3–1.8 1.4–4.7 † 0.74
NormJerk, adim 72–356 227–24 823 † 0.63
Values of instrumental indices used to assess upper limb reaching motion
(10th – 90th percentile range) in healthy subjects (N = 25) and the sample of
stroke patients enrolled in this study (N = 44). Statistical comparison was
assessed by the non-parametric Mann-Whitney U test. Effect size is reported
for significant differences. Legend: *p < 0.05; **p < 0.01; †p < 0.001
Fig. 1 Graphic representation of factor analysis results. All indices except meanVel/maxVel resulted in being grouped together within a specific
factor. Factor 1 deals with accuracy of movement trajectory, Factor 2 deals with trajectory smoothness and Factor 3 deals with velocity
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The correlation coefficients between the indices and
the WMFT-FAS and WMFT-TIME have similar absolute
values and opposite signs. This result is due to the fact
that the WMFT-TIME decreases with patient improve-
ment, whilst the WMFT-FAS increases with patient
improvement. The lower the WMFT-FAS was, the
lower were the accuracy and/or velocity and/or
smoothness of the movements. Similarly, the longer
the WMFT-TIME was, the lower were accuracy, vel-
ocity and/or smoothness.
Among the indices that describe movement accuracy,
HPR, which is related to overall accuracy during the ges-
ture, was correlated with both the WMFT-FAS and the
WMFT-TIME, while the local accuracy index and the
overshooting indices (Table 2) did not. Consequently,
the HPR can be used to provide a quantitative assess-
ment of an individual’s UL movement accuracy. Among
indices based on endpoint velocity, meanVel was corre-
lated with the WMFT-FAS and almost significantly cor-
related (p = 0.082) with the WMFT-TIME. Therefore, in
stroke patients, meanVel can be used to provide a quan-
titative assessment of an individual’s overall UL speed.
Indices assessing trajectory smoothness presented a
strongly significant correlation (p < 0.001) with both the
WMFT-FAS and the WMFT-TIME and can be used to
provide a quantitative assessment of an individual’s UL
movement smoothness.
Construct validity of indices
Table 5 summarizes the performance of the indices in
terms of the ES in the comparison between stroke
patients and healthy subjects, the discriminant validity
and the concurrent validity. Based on Table 5, we se-
lected a single index for each of the assessed movement
domains, which are HPR for accuracy, meanVel for vel-
ocity and NVelPeaks for smoothness. We consider that
the number of peaks in the velocity profile, i.e. the num-
ber of movement units within a single reaching task, is
preferable to the NormJerk variable because of its ease
of computation and sharing with clinicians.
Indices added value to clinical routine
The added value to clinical assessment provided by the
indices can be seen in Figs. 2 and 3. Figure 2 presents
the scatterplot of the HPR versus WMFT-FAS. A coarse
linear trend can be appreciated. Interestingly, some
patient data are considerably distant from this trend; i.e.
patients with equal WMFT-FAS may have significantly
different HPR values.
A graphic representation of the indices for one of the
sample patients is presented in Fig. 3. In this plot, indi-
ces were computed for each single reaching movement,
grouped based on the movement direction and normal-
ized with respect to normal reference values. Conse-
quently, normal values are located on the circumference,
values below normal are located inside the circumfer-
ence and values above normal are located outside the
circumference. Figure 3 is useful to identify the direc-
tions for which UL movement is compromised. Direc-
tions 1–7 and 2–8 are those with the worst indices for
this patient.
Discussions
In this study, we investigated the validity of a set of in-
strumental indices, which were computed based on the
endpoint trajectory of the Armeo®Spring device and pre-
viously described in literature [30], in order to assess UL
movement performance in sub-acute stroke patients. In
more detail, we analyzed the following three aspects: the
ability of the indices to discriminate between stroke pa-
tients and healthy subjects; the discriminant validity of
the indices in assessing different movement domains;
the concurrent validity of the indices with the WMFT,
which is a clinical reference scale for assessment of re-
sidual UL function. The presence of all three above-
mentioned characteristics was used to state the con-
struct validity of the indices. The main result of this
study is the selection and validation of three indices that
assess residual UL motor ability in sub-acute stroke
patients in terms of accuracy, velocity and smoothness.
Our results confirmed the validity of the Hand Path
Ratio in the assessment of the overall difficulty of motor
execution and control [29]. In our study, HPR was
nearly 40 % higher in affected patients than in healthy
individuals (p < 0.001) and showed a good performance
when discriminating between stroke patients and normal
Table 4 Spearman’s rho correlation coefficient and statistical
significance (P Value) for both the WMFT Functional Ability
Score (WMFT-FAS) and the mean execution time (WMFT-TIME)
in relation to nine instrumental indices that assess trajectory
accuracy, velocity and smoothness during the execution of
Armeo®Spring-assisted upper limb reaching tasks
WMFT-FAS WMFT-TIME
Indices rho P value rho P value
HPR, % −0.36 0.018 0.44 0.003
horOs, cm −0.10 0.524 0.10 0.501
verOs, cm 0.036 0.815 0.07 0.659
locHPR, % −0.22 0.145 0.23 0.132
meanVel, cm/s 0.31 0.039 −0.26 0.082
maxVel, cm/s 0.15 0.328 −0.10 0.514
meanVel/maxVel, % 0.45 0.002 −0.44 0.003
NVelPeaks, adim −0.50 0.001 0.56 <0.001
NormJerk, adim −0.50 0.001 0.55 <0.001
Bold font is used to highlight statistically significant correlations (P < 0.05).
Within these results, the lack of correlation between WMFT and the local
accuracy index locHPR might be affected by a 2nd-type error
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subjects (|ES = 0.58|), in line with previous studies by
Coderre et al. [36] and Otaka et al. [27]. The HPR
showed a moderate correlation with the WMFT-FAS
and the WMFT-TIME (rho ~ 0.4) and, from the factor
analysis, it resulted as belonging to the accuracy domain
with minor influence from the lack of smoothness do-
main. This result is similar to available literature, in
which measurements of movement accuracy based on
the endpoint trajectory resulted correlated with the se-
verity of clinical symptoms in stroke patients, as summa-
rized in the systematic review by Nordin et al. [29].
Along with these similarities, the method described in
this study to assess residual UL ability in stroke patients
offers two improvements with respect to literature.
Firstly, the use of an adjustable weight support permits
the assessment of compromised patients right from the
early, sub-acute phase of their disease. Secondly, the se-
lected task allows for identifying the most compromised
movement directions, as shown in Fig. 3, an objective
that was also suggested in the conclusion of the review
by Nordin et al. [29] and in accordance with previous
conclusions from Colombo, Micera et al. [37].
Validity was not verified for the indices assessing local
accuracy. Only a few subjects presented difficulty in
keeping the cursor within the rectangle delineated by
the starting and ending points, as assessed by horizontal
overshooting (horOS) and vertical overshooting (verOS).
It is reasonable to suppose that overshoots were com-
parable to those of normal subjects due to the gravita-
tional support provided by the device. Likewise, the lack
of control in the target area, assessed by local HPR
(locHPR), did not differentiate stroke patients from
healthy subjects and did not significantly correlate with
the clinical reference standard. Finally, the lack of con-
current validity with both the WMFT-FAS and the
WMFT-TIME (Table 4) does not allow for further use of
these indices dealing with local accuracy in the assess-
ment of stroke patients.
Mean velocity was significantly reduced in our sample
when compared to the normal reference with a medium
ES, as per Cohen’s classification. It showed a moderate
correlation with the WMFT-FAS and the WMFT-TIME
and, from the factor analysis, it fell markedly within the
velocity domain with negligible contributions from other
domains. The validity of meanVel in assessing UL motor
impairment in stroke patients was proven by these re-
sults, which correspond to findings in literature, where
the mean endpoint velocity during reaching movements
was found to distinguish between acute and chronic
stroke patients [29] and to be related to the FMA score
in acute patients [28, 37].
Table 5 Summary of the results that allowed for the definition of the construct validity of the UL assessment carried out in this study








HPR, % Yes Yes Yes Yes
locHPR, % No Yes No
vertOS and horOS, cm No Yes No
Indices of velocity
meanVel, cm/s Yes Yes Yes Yes
maxVel, cm/s No Yes No
meanVel/maxVel, % Yes No Yes
Indices of smoothness
NVelPeaks, adim Yes Yes Yes Yes
NormJerk, adim Yes Yes Yes Yes
For each movement domain, at least one index satisfied all the requirements for construct validity
Fig. 2 Scatterplot of HPR versus WMFT-FAS. In general, HPR decreases
when WMFT-FAS increases. For a few subjects however, highlighted in
the figure, clinical assessment by the WMFT-FAS did not reveal a lack
of control in movement accuracy. Thanks to the weight support, even
the most compromised patients in the sample were able to complete
the task at the easiest level with a success rate ranging from 80
to 100 %
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In our study, the maximum velocity did not correlate
with clinical indicators of UL ability. This result could
be explained by the fact that the WMFT evaluates the
overall performance of patients, thus correlating to the
mean velocity, rather than the ability of completing a
task as fast as possible. In literature that deals with exo-
skeletons and robotic devices, peak velocity was found
to correlate with clinical scores in a few studies on the
MIT-Manus [28, 38]. However, this device calls for pla-
nar movements of the hand, hence differing from the 3D
movements required by the “Vertical Capture” task of
the Armeo®Spring device. In our study, the mean vel-
ocity discriminated stroke patients from healthy subjects
better than peak velocity. This distinction is similar to
the one we found between HPR and locHPR. Indeed,
meanVel is a global indicator that depends on the execu-
tion of the entire reaching movement, whilst peak vel-
ocity is a local indicator that does not take into account
for any other characteristics of the reaching movement.
An interesting comparison can be made with a study by
Edwards et al. [14]. They investigated a sample of sub-
acute stroke patients with UL motor performances simi-
lar to those of our sample (recruitment at 42 ± 40 days
after lesion) by assessing both the WMFT and a set of
kinematic variables computed from motion capture data.
Interestingly, the wrist peak velocity measured during a
reaching task was much higher (62 ± 35 cm/s) compared
to the one obtained in our sample. In contrast, during a
“reach to grasp” task of a small cylinder peak velocity
was lower (11 ± 9 cm/s) and similar to the one we ob-
tained in this study. The former difference could be
accounted for because, in our study, the subjects were
not able to lean their trunk towards the target during
the assisted task, since the UL was fitted to the exoskel-
eton. Leaning the trunk forward is the main compensa-
tory mechanism used by stroke patients with impaired
elbow extension when reaching for a target and results
Fig. 3 Graphic representation of computed indices for one patient
in the sample, based on the “Vertical Capture” task of the Armeo®Spring
device being repeated three consecutive times. Similarly to a clock, the
numbers indicate movements in a specific direction (e.g. 1–7, or 3–9).
Indices were grouped based on the direction of the movement and
normalized to the normal reference value for that direction.
The median value was then computed and plotted. Due to
the normalization procedure, values close to the normal
reference are close to the circumference; values greater than
normal are outside the circumference (as per HPR) and values
lower than normal are inside the circumference (as per meanVel).
This representation provides a glimpse of one patient’s UL movement
impairment. This subject displayed jerky movements with reduced
velocity but displayed sufficient control of the movement trajectory.
Directions 1–7 and 2–8 appear to be the most compromised. A better
overall accuracy (HPR) was achieved in the horizontal movements
(direction 3–9), possibly due to a greater control ability, despite
jerkiness (NVelPeaks), which resulted in a lower velocity (meanVel)
Longhi et al. Journal of NeuroEngineering and Rehabilitation  (2016) 13:52 Page 8 of 11
in higher endpoint velocity [39]. The latter similarity
could be accounted for by the need for similar control at
the end of the reaching movement. This might result in
similar low peak velocities during the task. The con-
trol of trunk compensatory mechanisms made pos-
sible by the exoskeleton used in this study is a
further improvement in the instrumental assessment
of UL function, as recommended in the review by
Nordin and colleagues [29].
The presence of jerky movements was assessed by
both smoothness indices used in this study (NVelPeak
and NormJerk). The number of velocity peaks during
reaching movements reflects the presence of “sub-move-
ments” [28, 38], or “movement units” [40, 41], and tends
to decrease when smoothness improves [42]. In our
study on 3D movements of the UL, these two indices
showed a high ability in discriminating between patients
and healthy individuals (|ES| = 0.74 and |ES| = 0.63) and
a statistically significant (p < 0.001) medium to large cor-
relation (rho = 0.50–0.56) with the clinical reference
standard, showing the best performance in describing
the ability of stroke patients across the entire set of indi-
ces. Factor analysis confirmed that the NVelPeak and
NormJerk fell within the specific domain of lack of
smoothness, distinctly from movement accuracy and vel-
ocity. These results appear to be in accordance with the
physiopathology of motor impairment in subjects who
have suffered a stroke, which is characterized by im-
paired recruitment and de-recruitment, exaggerated re-
flexes to fast stretches (spasticity), muscle shortening
coupled by increased stiffness, abnormal muscle patterns
and co-contractions, resulting in movement fragmenta-
tion [43]. In literature, the number of peaks in the speed
profile has been used to quantify trajectory smoothness
in reaching tasks performed by stroke patients in the 2D
[28] and 3D-Space [14, 44] and was found to correlate
with the clinical stage of motor recovery, in accordance
with our results. Similarly, the number of peaks in the
hand velocity profile obtained by Colombo et al. [45]
and by Otaka et al. [27] was significantly correlated with
clinical scales, including the WMFT-FAS. Interestingly,
these results were obtained with various robotic devices
and exoskeletons, consequently suggesting that the num-
ber of peaks in the endpoint velocity profile, during
reaching tasks, can be used as an assessment tool for
smoothness impairment regardless of the type of robotic
device used.
While the majority of published results deals with
chronic stroke patients, the robotic assessment described
in this study is based on the validation of indices in a
sample of patients in the sub-acute stage of the disease,
which is when most rehabilitation is carried out, and
when the need for UL performance assessment is great-
est. The focus on early-stage stroke patients of this study
goes beyond what is present in current literature, where
validation of clinical indices was often investigated in
chronic patients [27, 38, 46]. Chronic patients are generally
clinically stable and easier to enroll, but present a low de-
gree of potential recovery. Assessment of sub-acute in-
patients was made possible by the UL weight support of
the chosen device, which allowed for even very weak pa-
tients to be tested at the start of their rehabilitation. The
inclusion of highly compromised in-patients also goes be-
yond what is present in current literature. As measured by
the MI (see Table 1), the paresis level ranged from moder-
ate to normal (i.e. MI = 14 and MI = 33 at elbow and/or
shoulder respectively), thus covering a very wide range of
motor impairments and giving external validity to our re-
sults. In this approach, besides identifying the most com-
promised directional movements, it becomes possible to
track longitudinal changes in the motor recovery of stroke
patients by repeating instrumental measurements through-
out the rehabilitation period.
The selection of the WMFT as the reference standard,
as in reference [14], was appropriate for the validation
purpose of our study. In fact, the WMFT scale assesses
overall UL limitations, according to the ICF activity do-
main [10, 11]. In contrast, other clinical scales for UL
evaluation used in studies on robotic indices, such as the
FMA and the Brunnstrom Recovery Stage, focus only on
motor impairment that is related to the body function
and structure ICF domain. Moreover, the “Vertical Cap-
ture” task chosen for this study allows for the assess-
ment of 3D reaching movements, which are essential for
many everyday activities [27] and, therefore, preferable
to the 2D movements called for by planar robots and
closer to the WMFT setting for clinical assessment of
function. As the indices are computed from data ac-
quired during the “Vertical Capture” task with the
Armeo®Spring device, it is essential that this specific task
be used only to assess UL function and not as a training
task throughout the rehabilitation period.
We consider these indices to offer a fast and useful
support in the UL rehabilitation of stroke patients, as
they can be obtained just prior to commencing a re-
habilitation session, by the same operator, in the same
place and without any special preparation. Moreover, in-
strumental indices can be repeated many times to obtain
a mean value which can prove more robust than a single
score obtained by clinical scales [26]. Finally, the indices
were able to detect differences in accuracy, velocity or
smoothness in patients with the same WMFT-FAS and
WMFT-TIME, showing greater sensitivity than clinical
scales in measuring motor recovery in stroke patients, in
accordance with literature [26]. Thus, indices can be
used both to improve the decision making in UL re-
habilitation and to assess the effectiveness of the deliv-
ered treatment.
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This study had some limitations. We did not control
the positions in which the targets appeared on the
screen; these were randomly generated by the device’s
software. As a result, identifying the most compromised
directional movement can be inaccurate if a patient can
complete the easiest task only (level 1), with no more
than randomly generated 12 targets. The acquisition of
three consecutive trials at the maximum difficulty level
according to individual patient’s ability should have min-
imized this possible error.
From a methodological point of view, a repeatability
study between two sessions should be carried out in
order to determine the minimum significant variation of
the selected indices [30], for patients with the same in-
clusion/exclusion criteria. A longitudinal study should
also be carried out to evaluate the responsiveness and
expected change of the selected indices in relation to the
clinical improvement in the UL motor ability of stroke
patients. Finally, future studies could validate the use of
this set of indices with other neurological conditions.
Conclusions
Construct validity has been proven for three of the in-
vestigated indices: the hand path ratio, the mean velocity
and the number of peaks in the velocity profile, which
assess movement accuracy, velocity and smoothness, re-
spectively, and can be used as tools to integrate clinical
evaluation of UL function in stroke patients from the
sub-acute recovery stage.
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